(TMCI) Stock Forecast, Price Target & Predictions

OverviewRevenue Financials Chart Transcripts

TMCI Stock Forecast

stock forecast is as follows: an average price target of $14.50 (represents a 53.28% upside from TMCI’s last price of $9.46) and a rating consensus of 'Buy', based on 4 wall street analysts offering a 1-year stock forecast.

TMCI Price Target

The average price target for (TMCI) is $14.50 based on 1-year price targets from 4 Wall Street analysts in the past 3 months, with a price target range of $14.50 to $14.50. This represents a potential 53.28% upside from TMCI's last price of $9.46.

TMCI Analyst Ratings

Buy

According to 4 Wall Street analysts, 's rating consensus is 'Buy'. The analyst rating breakdown for TMCI stock is 0 'Strong Buy' (0.00%), 2 'Buy' (50.00%), 2 'Hold' (50.00%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).

Price Target by Analyst

Date	Analyst	Company	Price Target	Price when Published	Price Target/Price when Published	Price Target/Last Closing Price
Dec 31, 2024	Ben Haynor	Lake Street	$14.50	$7.44	94.89%	53.28%
May 16, 2024	Danielle Antalffy	UBS	$6.50	$5.95	9.24%	-31.29%
Sep 21, 2022		BTIG	$28.00	$23.95	16.93%	195.98%
Sep 21, 2022		Stifel Nicolaus	$27.00	$23.87	13.11%	185.41%
Jul 18, 2022		Stifel Nicolaus	$21.00	$16.29	28.91%	121.99%

The latest stock forecast, released on Dec 31, 2024 by Ben Haynor from Lake Street, set a price target of $14.50, which represents a 94.89% increase from the stock price at the time of the forecast ($7.44), and a 53.28% increase from TMCI last price ($9.46).

Price Target by Period

	1M	3M	12M
# Anlaysts	1	1	2
Avg Price Target	$14.50	$14.50	$10.50
Last Closing Price	$9.46	$9.46	$9.46
Upside/Downside	53.28%	53.28%	10.99%

In the current month, the average price target of stock is $14.50, according to 1 Wall Street analyst offering twelve months forecast. The average price target represents a 53.28% increase as opposed to 's last price of $9.46. This month's average price target is down 0.00% compared to last quarter, and up 38.10% compared to last year.

Analyst Ratings Upgrades/Downgrades

Date	Company	Previous Rating	New Rating	Rating Change
Dec 31, 2024	Lake Street		Buy	Initialise
Jul 15, 2024	Morgan Stanley	Equal-Weight	Equal-Weight	Hold
May 16, 2024	UBS	Buy	Neutral	Downgrade
Dec 22, 2023	UBS	Buy	Buy	Hold
Dec 22, 2023	Truist Financial	Underperform	Underperform	Hold
Sep 21, 2022	BTIG	Buy	Buy	Hold

's last stock rating was published by Lake Street on Dec 31, 2024. The company Initialise its TMCI rating from "null" to "Buy".

Financial Forecast

Revenue Forecast

	Dec 26	Sep 26	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21
Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	$42.20M	$49.77M	$33.05M	$29.97M	$29.05M	$33.44M	$21.62M	$20.65M	$18.71M
Avg Forecast	$84.52M	$54.35M	$54.01M	$57.97M	$74.78M	$48.79M	$49.36M	$52.70M	$67.25M	$43.48M	$43.00M	$49.07M	$60.56M	$41.64M	$40.84M	$39.25M	$44.81M	$30.13M	$28.69M	$26.03M	$32.36M	$21.06M	$18.93M	$18.77M
High Forecast	$87.71M	$56.40M	$56.04M	$60.15M	$77.59M	$50.63M	$51.22M	$53.30M	$67.93M	$43.56M	$43.00M	$49.07M	$60.61M	$41.88M	$42.38M	$40.72M	$46.13M	$30.13M	$28.69M	$26.03M	$32.36M	$21.06M	$18.93M	$18.77M
Low Forecast	$81.77M	$52.58M	$52.25M	$56.08M	$72.34M	$47.20M	$47.75M	$52.24M	$66.69M	$43.40M	$43.00M	$49.07M	$60.51M	$41.41M	$39.51M	$37.97M	$43.89M	$30.13M	$28.69M	$26.03M	$32.36M	$21.06M	$18.93M	$18.77M
# Analysts	1	1	1	1	1	1	1	3	2	1	2	2	4	2	2	2	1	1	1	1	2	2	2	2
Surprise %	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	1.08%	1.11%	1.10%	1.04%	1.12%	1.03%	1.03%	1.09%	1.00%

's average Quarter revenue forecast for Jun 23 based on 2 analysts is $40.84M, with a low forecast of $39.51M, and a high forecast of $42.38M. TMCI's average Quarter revenue forecast represents a -3.21% decrease compared to the company's last Quarter revenue of $42.20M (Mar 23).

EBITDA Forecast

	Dec 26	Sep 26	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21
# Analysts	1	1	1	1	1	1	1	3	2	1	2	2	4	2	2	2	1	1	1	1	2	2	2	2
EBITDA	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	$-11.24M	$-3.10M	$-10.48M	$-11.80M	$-7.75M	$-5.32M	$-5.27M	$-3.94M	$-1.28M
Avg Forecast	$-11.03M	$-7.09M	$-7.05M	$-7.56M	$-9.76M	$-6.36M	$-6.44M	$-6.88M	$-8.77M	$-5.67M	$-5.61M	$-6.40M	$-7.90M	$-5.43M	$-5.33M	$-5.12M	$-5.85M	$-4.21M	$-4.01M	$-9.31M	$-4.52M	$-2.94M	$-2.65M	$-1.07M
High Forecast	$-10.67M	$-6.86M	$-6.82M	$-7.32M	$-9.44M	$-6.16M	$-6.23M	$-6.81M	$-8.70M	$-5.66M	$-5.61M	$-6.40M	$-7.89M	$-5.40M	$-5.15M	$-4.95M	$-5.73M	$-4.21M	$-4.01M	$-7.45M	$-4.52M	$-2.94M	$-2.65M	$-856.00K
Low Forecast	$-11.44M	$-7.36M	$-7.31M	$-7.85M	$-10.12M	$-6.60M	$-6.68M	$-6.95M	$-8.86M	$-5.68M	$-5.61M	$-6.40M	$-7.91M	$-5.46M	$-5.53M	$-5.31M	$-6.02M	$-4.21M	$-4.01M	$-11.18M	$-4.52M	$-2.94M	$-2.65M	$-1.28M
Surprise %	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	2.20%	0.53%	2.49%	2.94%	0.83%	1.17%	1.79%	1.49%	1.20%

undefined analysts predict TMCI's average Quarter EBITDA for undefined to be $NaN, with a high of $NaN and a low of $NaN. This is NaN% lower than 's previous annual EBITDA (undefined) of $NaN.

Net Income Forecast

	Dec 26	Sep 26	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21
# Analysts	1	1	1	1	1	1	1	3	2	1	2	2	4	2	2	2	1	1	1	1	2	2	2	2
Net Income	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	$-13.13M	$-3.50M	$-12.95M	$-21.29M	$-9.98M	$-7.65M	$-6.42M	$-5.08M	$-2.43M
Avg Forecast	$5.28M	$-10.29M	$-15.25M	$-16.39M	$-1.97M	$-12.87M	$-15.42M	$-15.79M	$-2.39M	$-16.91M	$-18.10M	$-18.79M	$-5.49M	$-16.44M	$-15.00M	$-14.24M	$-8.67M	$-17.79M	$-12.82M	$-12.57M	$-359.64K	$-7.40M	$-7.45M	$-2.03M
High Forecast	$5.54M	$-9.85M	$-14.61M	$-15.70M	$-1.89M	$-12.32M	$-14.77M	$-12.63M	$-1.60M	$-16.19M	$-17.33M	$-18.00M	$-2.44M	$-15.75M	$-14.36M	$-13.64M	$-8.44M	$-17.79M	$-12.82M	$-12.57M	$-359.64K	$-7.40M	$-7.45M	$-1.62M
Low Forecast	$5.06M	$-10.79M	$-16.00M	$-17.20M	$-2.07M	$-13.50M	$-16.18M	$-17.68M	$-3.99M	$-17.73M	$-18.98M	$-19.71M	$-9.16M	$-17.25M	$-15.73M	$-14.94M	$-9.01M	$-17.79M	$-12.82M	$-12.57M	$-359.64K	$-7.40M	$-7.45M	$-2.43M
Surprise %	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0.92%	0.40%	0.73%	1.66%	0.79%	21.26%	0.87%	0.68%	1.20%

's average Quarter net income forecast for undefined is $NaN, with a range of $NaN to $NaN. TMCI's average Quarter net income forecast represents a NaN% decrease compared to the company's last Quarter net income of $NaN (undefined).

SG&A Forecast

	Dec 26	Sep 26	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21
# Analysts	1	1	1	1	1	1	1	3	2	1	2	2	4	2	2	2	1	1	1	1	2	2	2	2
SG&A	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	$44.52M	$39.77M	$33.95M	$33.27M	$28.59M	$29.35M	$20.29M	$18.34M	$14.91M
Avg Forecast	$72.20M	$46.43M	$46.14M	$49.52M	$63.88M	$41.68M	$42.16M	$45.02M	$57.45M	$37.14M	$36.73M	$41.92M	$51.74M	$35.57M	$34.89M	$33.53M	$38.28M	$25.74M	$24.51M	$22.24M	$27.64M	$17.99M	$16.17M	$12.43M
High Forecast	$74.92M	$48.18M	$47.88M	$51.39M	$66.29M	$43.25M	$43.75M	$45.53M	$58.03M	$37.21M	$36.73M	$41.92M	$51.78M	$35.77M	$36.21M	$34.79M	$39.41M	$25.74M	$24.51M	$22.24M	$27.64M	$17.99M	$16.17M	$14.91M
Low Forecast	$69.85M	$44.92M	$44.63M	$47.91M	$61.80M	$40.32M	$40.79M	$44.62M	$56.97M	$37.08M	$36.73M	$41.92M	$51.69M	$35.37M	$33.75M	$32.43M	$37.49M	$25.74M	$24.51M	$22.24M	$27.64M	$17.99M	$16.17M	$9.94M
Surprise %	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	1.33%	1.04%	1.32%	1.36%	1.29%	1.06%	1.13%	1.13%	1.20%

's average Quarter SG&A projection for Jun 23 is $34.89M, based on 2 Wall Street analysts, with a range of $33.75M to $36.21M. The forecast indicates a -21.63% fall compared to TMCI last annual SG&A of $44.52M (Mar 23).

EPS Forecast

	Dec 26	Sep 26	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21
# Analysts	1	1	1	1	1	1	1	3	2	1	2	2	4	2	2	2	1	1	1	1	2	2	2	2
EPS	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	$-0.22	$-0.06	$-0.23	$-0.39	$-0.18	$-0.14	$-0.12	$-0.10	$-0.05
Avg Forecast	$0.08	$-0.17	$-0.25	$-0.26	$-0.03	$-0.21	$-0.25	$-0.25	$-0.04	$-0.27	$-0.29	$-0.30	$-0.09	$-0.26	$-0.24	$-0.23	$-0.14	$-0.29	$-0.21	$-0.20	$-0.01	$-0.12	$-0.12	$-0.08
High Forecast	$0.09	$-0.16	$-0.23	$-0.25	$-0.03	$-0.20	$-0.24	$-0.20	$-0.03	$-0.26	$-0.28	$-0.29	$-0.04	$-0.25	$-0.23	$-0.22	$-0.14	$-0.29	$-0.21	$-0.20	$-0.01	$-0.12	$-0.12	$-0.08
Low Forecast	$0.08	$-0.17	$-0.26	$-0.28	$-0.03	$-0.22	$-0.26	$-0.28	$-0.06	$-0.28	$-0.31	$-0.32	$-0.15	$-0.28	$-0.25	$-0.24	$-0.14	$-0.29	$-0.21	$-0.20	$-0.01	$-0.12	$-0.12	$-0.08
Surprise %	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0.96%	0.45%	0.80%	1.89%	0.89%	24.17%	1.01%	0.83%	0.64%

According to undefined Wall Street analysts, 's projected average Quarter EPS for undefined is $NaN, with a low estimate of $NaN and a high estimate of $NaN. This represents a NaN% decrease compared to TMCI previous annual EPS of $NaN (undefined).

Peer Comparison by Price Target

Ticker	Company	Last Closing Price	Avg Price Target	Upside/Downside	Avg Rating
SGHT	Sight Sciences	$3.13	$7.50	139.62%	Hold
RXST	RxSight	$31.85	$70.14	120.22%	Buy
LUNG	Pulmonx	$6.05	$13.00	114.88%	Buy
KIDS	OrthoPediatrics	$25.05	$39.50	57.68%	Buy
TMCI	Treace Medical Concepts	$9.46	$14.50	53.28%	Buy
CNMD	CONMED	$70.97	$97.00	36.68%	Buy
ESTA	Establishment Labs	$33.00	$45.00	36.36%	Buy
LIVN	LivaNova	$50.53	$67.00	32.59%	Buy
OFIX	Orthofix Medical	$18.59	$24.00	29.10%
SRDX	Surmodics	$35.79	$39.50	10.37%	Buy
ITGR	Integer	$144.36	$153.50	6.33%	Buy
NPCE	NeuroPace	$14.13	$15.00	6.16%	Buy
IRMD	IRadimed	$60.70	$60.00	-1.15%	Buy
FNA	Paragon 28	$12.00	$11.50	-4.17%	Buy
TCMD	Tactile Systems	$17.99	$16.00	-11.06%	Buy

TMCI Forecast FAQ

Is a good buy?

Yes, according to 4 Wall Street analysts, (TMCI) is considered a 'Buy'. The rating consensus is based on 0 'Strong Buy' and 2 'Buy' recommendations, accounting for 50.00% of TMCI's total ratings.

What is TMCI's price target?

(TMCI) average price target is $14.5 with a range of $14.5 to $14.5, implying a 53.28% from its last price of $9.46. The data is based on 4 Wall Street analysts who provided a twelve-month price target estimate in the last three months.

Will stock go up soon?

According to Wall Street analysts' prediction for TMCI stock, the company can go up by 53.28% (from the last price of $9.46 to the average price target of $14.5), up by 53.28% based on the highest stock price target, and up by 53.28% based on the lowest stock price target.

Can stock reach $14?

TMCI's average twelve months analyst stock price target of $14.5 supports the claim that can reach $14 in the near future.

What is 's current price target trend?

1 Wall Street analyst forecast a $14.5 price target for (TMCI) this month, up 53.28% from its last price of $9.46. Compared to the last 3 and 12 months, the average price target increased by 53.28% and increased by 10.99%, respectively.

What are 's analysts' financial forecasts?

's analysts financial forecasts for the fiscal year (Dec 2025) are as follows: average revenue is $225.62M (high $232.74M, low $219.53M), average EBITDA is $-29.434M (high $-28.639M, low $-30.363M), average net income is $-46.05M (high $-41.611M, low $-49.427M), average SG&A $192.74M (high $198.82M, low $187.54M), and average EPS is $-0.74 (high $-0.669, low $-0.794). TMCI's analysts financial forecasts for the fiscal year (Dec 2026) are as follows: average revenue is $250.84M (high $260.3M, low $242.67M), average EBITDA is $-32.725M (high $-31.659M, low $-33.958M), average net income is $-36.652M (high $-34.619M, low $-38.93M), average SG&A $214.29M (high $222.37M, low $207.31M), and average EPS is $-0.589 (high $-0.556, low $-0.626).

Did the TMCI's actual financial results beat the analysts' financial forecasts?

Based on 's last annual report (Dec 2022), the company's revenue was $141.84M, beating the average analysts forecast of $129.66M by 9.39%. Apple's EBITDA was $-31.801M, beating the average prediction of $-23.383M by 36.00%. The company's net income was $-47.298M, missing the average estimation of $-51.851M by -8.78%. Apple's SG&A was $135.58M, beating the average forecast of $110.77M by 22.40%. Lastly, the company's EPS was $-0.86, beating the average prediction of $-0.835 by 3.01%. In terms of the last quarterly report (Mar 2023), 's revenue was $42.2M, beating the average analysts' forecast of $39.25M by 7.52%. The company's EBITDA was $-11.245M, beating the average prediction of $-5.12M by 119.63%. 's net income was $-13.132M, missing the average estimation of $-14.239M by -7.78%. The company's SG&A was $44.52M, beating the average forecast of $33.53M by 32.79%. Lastly, the company's EPS was $-0.22, missing the average prediction of $-0.229 by -3.85%